» Articles » PMID: 36638315

Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance

Overview
Date 2023 Jan 13
PMID 36638315
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal tumors harboring various kinase fusions were recently recognized as emerging entities mainly in the soft tissues. We herein investigate the clinicopathologic and molecular characteristics of head and neck mesenchymal tumors harboring kinase fusions. The study cohort included 15 patients with a median age of 13 years (ranging from congenital to 63 y). The kinase genes involved in descending order were NTRK1 (n=6), NTRK3 (n=5), BRAF (n=2), and 1 each with MET, and RET. The anatomic locations were broad involving all tissue planes, including skin (n=4), intraosseous (n=4), major salivary glands (n=2), sinonasal tract (n=2), soft tissue of face or neck (n=2), and oral cavity (n=1). The histologic spectrum ranged from benign to high grade, in descending order including tumors resembling malignant peripheral nerve sheath tumor (MPNST)-like, fibrosarcoma (infantile or adult-type), lipofibromatosis-like neural tumor (LPFNT), inflammatory myofibroblastic tumor-like, and a novel phenotype resembling myxoma. Perivascular hyalinization/stromal keloid-like collagen bands and staghorn vasculature were common features in MPNST-like and LPFNT-like tumors. Two tumors (1 each with NTRK1 or BRAF rearrangement) were classified as high grade. By immunohistochemistry, S100 and CD34 positivity was noted in 71% and 60%, frequently in MPNST-like and LPFNT-like phenotypes. Pan-TRK was a sensitive marker for NTRK-translocated tumors but was negative in tumor with other kinase fusions. One patient with a high-grade tumor developed distant metastasis. Molecular testing for various kinase fusions should be considered for S100+/CD34+ spindle cell neoplasms with perivascular hyalinization and staghorn vessels, as pan-TRK positivity is seen only in NTRK fusions.

Citing Articles

PDGFRA::USP8 Fusion in a Cutaneous Inflammatory Myofibroblastic Tumor, Highlighting Genetic Pleiotropy of Kinase Gene Fusions in Soft Tissue Neoplasms.

Vernemmen A, van Kempen L, Aarts F, Zur Hausen A, Sciot R, Hornick J Genes Chromosomes Cancer. 2025; 64(2):e70035.

PMID: 39950323 PMC: 11826371. DOI: 10.1002/gcc.70035.


What is new in fibroblastic/myofibroblastic tumors in children.

Al-Ibraheemi A, Zhou Y, Rullo E, Alaggio R Virchows Arch. 2024; 486(1):127-141.

PMID: 39499317 DOI: 10.1007/s00428-024-03964-9.


Therapy among Different Types of Cancers, Review and Future Perspectives.

Theik N, Muminovic M, Alvarez-Pinzon A, Shoreibah A, Hussein A, Raez L Int J Mol Sci. 2024; 25(4).

PMID: 38397049 PMC: 10889397. DOI: 10.3390/ijms25042366.


Spindle Cell Tumors of the Sinonasal Tract: A Diagnostic Update with Focus on Ancillary Workup.

Almohsen S, Demicco E Head Neck Pathol. 2024; 18(1):8.

PMID: 38363429 PMC: 10873262. DOI: 10.1007/s12105-023-01605-2.


Molecular pathology in diagnosis and prognostication of head and neck tumors.

Skalova A, Bradova M, Michal Jr M, Mosaieby E, Klubickova N, Vanecek T Virchows Arch. 2024; 484(2):215-231.

PMID: 38217715 PMC: 10948559. DOI: 10.1007/s00428-023-03731-2.